Clinical trials
Terminated Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,157 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 11 |
| 2002 | 22 |
| 2003 | 25 |
| 2004 | 34 |
| 2005 | 36 |
| 2006 | 42 |
| 2007 | 68 |
| 2008 | 70 |
| 2009 | 74 |
| 2010 | 68 |
| 2011 | 58 |
| 2012 | 51 |
| 2013 | 57 |
| 2014 | 49 |
| 2015 | 59 |
| 2016 | 62 |
| 2017 | 55 |
| 2018 | 53 |
| 2019 | 61 |
| 2020 | 44 |
| 2021 | 37 |
| 2022 | 41 |
| 2023 | 29 |
| 2024 | 11 |
| 2025 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 1,157 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 39 |
| M.D. Anderson Cancer Center | 32 |
| Pfizer | 27 |
| Novartis Pharmaceuticals | 22 |
| Hoffmann-La Roche | 20 |
| Vanderbilt-Ingram Cancer Center | 16 |
| Mayo Clinic | 15 |
| Dana-Farber Cancer Institute | 14 |
| University of Southern California | 14 |
| Washington University School of Medicine | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 1,157 |
| Neoplasm Metastasis | 84 |
| Neoplasms | 66 |
| Ovarian Neoplasms | 65 |
| Lung Neoplasms | 60 |
| Triple Negative Breast Neoplasms | 57 |
| Colorectal Neoplasms | 53 |
| Carcinoma, Non-Small-Cell Lung | 48 |
| Breast Neoplasms, Male | 42 |
| Prostatic Neoplasms | 41 |
Trials
Showing 1 to 25 of 1,157. Each trial links to its page on Pharma Observatory.
1,057 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.